ANDSecurities Purchase Agreement • December 19th, 2003 • Skyepharma PLC • Pharmaceutical preparations • New York
Contract Type FiledDecember 19th, 2003 Company Industry Jurisdiction
BY AND AMONG BRADLEY D. EDSON STUART A. BENSON DONALD HANNAH SKYEPHARMA PLC STEPHEN MORRIS FIFTH AVENUE CAPITAL, INC. AND VITAL LIVING, INC. (A NEVADA CORPORATION)Stockholders' Agreement • August 29th, 2003 • Skyepharma PLC • Pharmaceutical preparations • New York
Contract Type FiledAugust 29th, 2003 Company Industry Jurisdiction
STOCK PURCHASE AGREEMENT by and between DEPOTECH CORPORATIONStock Purchase Agreement • October 29th, 1998 • Skyepharma PLC • Pharmaceutical preparations • California
Contract Type FiledOctober 29th, 1998 Company Industry Jurisdiction
Exhibit 5 VITAL LIVING, INC. REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (the "Agreement"), dated as of December 15, 2003, is made by and between Vital Living, Inc., a Nevada corporation (the "Company"), and the individuals and...Registration Rights Agreement • December 19th, 2003 • Skyepharma PLC • Pharmaceutical preparations • New York
Contract Type FiledDecember 19th, 2003 Company Industry Jurisdiction
AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • November 12th, 1998 • Skyepharma PLC • Pharmaceutical preparations • California
Contract Type FiledNovember 12th, 1998 Company Industry Jurisdiction
EXHIBIT 4 AMENDMENT NO. 1 TO STOCKHOLDERS AGREEMENTStockholders Agreement • January 22nd, 2004 • Skyepharma PLC • Pharmaceutical preparations • New York
Contract Type FiledJanuary 22nd, 2004 Company Industry Jurisdiction
EXHIBIT 2 SUBSCRIPTION AGREEMENTSubscription Agreement • August 29th, 2003 • Skyepharma PLC • Pharmaceutical preparations • New York
Contract Type FiledAugust 29th, 2003 Company Industry Jurisdiction
Exhibit 7 SECURITY AGREEMENT ------------------ AGREEMENT dated as of December 15, 2003, between VITAL LIVING, INC., a Nevada corporation, having an address at 5080 North 40th Street, Suite 105, Phoenix, Arizona 85018 (the "Company"), the persons and...Security Agreement • December 19th, 2003 • Skyepharma PLC • Pharmaceutical preparations • New York
Contract Type FiledDecember 19th, 2003 Company Industry Jurisdiction
EXHIBIT 2 AMENDMENT OF STOCK PURCHASE AGREEMENTStock Purchase Agreement • June 27th, 2000 • Skyepharma PLC • Pharmaceutical preparations
Contract Type FiledJune 27th, 2000 Company Industry
RECITALSCall Option Agreement • January 22nd, 2004 • Skyepharma PLC • Pharmaceutical preparations • New York
Contract Type FiledJanuary 22nd, 2004 Company Industry Jurisdiction
Exhibit A to Deposit AgreementDeposit Agreement • June 4th, 2007 • Skyepharma PLC • Pharmaceutical preparations
Contract Type FiledJune 4th, 2007 Company IndustryThe Bank of New York as depositary (hereinafter called the "Depositary"), hereby certifies that ________________________, or registered assigns IS THE OWNER OF _____________________________________
VITAL LIVING, INC. 5080 N. 40th Street Suite 105 Phoenix, Arizona 85018Skyepharma PLC • December 19th, 2003 • Pharmaceutical preparations
Company FiledDecember 19th, 2003 IndustryReference is made to the Senior Secured Convertible Note (the "Note") and the Warrant (the "Warrant"), each as entered into by and between SkyePharma PLC ("SkyePharma") and Vital Living, Inc. ("Vital Living"), on the date hereof. Vital Living hereby agrees as follows, which agreements shall be in addition to its obligations with respect to delivering the Redemption Notices, as defined in each of the Note and the Warrant, contained in the Preamble, Section 4 and Section 13 of the Note and the Section 1, Section 8 and Section 12 of the Warrant, to SkyePharma. Vital Living agrees that, in the case of Redemption Notices sent pursuant to the Preamble and Section 13 of the Note and Section 8 and Section 12 of the Warrant, but not in the case of Section 4 of the Note, upon conclusion of the twenty (20) business day notice period specified in such sections, if SkyePharma has not provided written notice to Vital Living indicating that it is electing to accept the price for redemption specified
LICENSE AGREEMENT between SMITHKLINE BEECHAM plc and JAGOTEC AG and JAGO PHARMA AGLetter Agreement • June 28th, 2004 • Skyepharma PLC • Pharmaceutical preparations
Contract Type FiledJune 28th, 2004 Company IndustryThis LICENSE AGREEMENT (hereinafter "AGREEMENT"), made as of the 20th day of March, 1996 between Jagotec AG, a corporation organized under the laws of the country of Switzerland, having its principal place of business at Seestrasse 47, CH-6052, Hergiswil, Switzerland, JAGO Pharma AG, a corporation organized under the laws of the country of Switzerland, having its principal place of business at Eptingerstrasse 51, CH-4132 Muttenz, Switzerland, and SmithKline Beecham plc, a company organized under the laws of England and having its registered office at New Horizons Court, Brentford, Middlesex TW8 9EP, England, operating as SmithKline Beecham Pharmaceuticals.
RECITALSOmnibus Conversion Agreement • January 15th, 2004 • Skyepharma PLC • Pharmaceutical preparations • New York
Contract Type FiledJanuary 15th, 2004 Company Industry Jurisdiction
EXHIBIT 1 VITAL LIVING REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (the "Agreement"), dated as of August 20, 2003, is between SkyePharma PLC, a company incorporated under the laws of England and Wales (the "Holder") and Vital...Vital Living Registration Rights Agreement • August 29th, 2003 • Skyepharma PLC • Pharmaceutical preparations • New York
Contract Type FiledAugust 29th, 2003 Company Industry Jurisdiction
VITAL LIVING REGISTRATION RIGHTS AGREEMENTVital Living Registration Rights Agreement • June 27th, 2006 • Skyepharma PLC • Pharmaceutical preparations • New York
Contract Type FiledJune 27th, 2006 Company Industry JurisdictionThis Registration Rights Agreement (the “Agreement”), dated as of June 13, 2006, is between SkyePharma PLC, a company incorporated under the laws of England and Wales (the “Holder”) and Vital Living, Inc., a Nevada corporation (the “Corporation”).
SKYEPHARMA LETTERHEAD] Vital Living, Inc. 5080 North 40th Street, Suite 105 Phoenix, Arizona 85018-2158 United States 19 November 2003 We refer to the letter, dated as of 20 August 2003, from SkyePharma PLC to you ("Vital Living"), executed in...Skyepharma PLC • November 21st, 2003 • Pharmaceutical preparations
Company FiledNovember 21st, 2003 Industry
AGREEMENT DATED AS OF JUNE 13, 2006 AMONG VITAL LIVING, INC., SKYEPHARMA PLC, AND VTLV LLCAgreement • June 27th, 2006 • Skyepharma PLC • Pharmaceutical preparations • New York
Contract Type FiledJune 27th, 2006 Company Industry JurisdictionWHEREAS, Skye owns $1,000,000 in aggregate principal amount of the Company’s Senior Secured Convertible Notes acquired pursuant to the Securities Purchase Agreement by and among the Company and several investors, including Skye, dated as of December 15, 2003 (as amended September 16, 2004, October 26, 2004, and November 15, 2004) (the “Convertible Notes”), and 1,000,000 shares of the Company’s Series D Preferred Stock, par value $0.001 per share, acquired pursuant to the Subscription Agreement by and between the Company and Skye, dated as of August 15, 2003 (the “Preferred Shares”);
Stock Purchase Agreement by and among Mike Ajnsztajn, Gaston Liebhaber and SkyePharma PLC Dated as of December 29, 2004Stock Purchase Agreement • December 29th, 2004 • Skyepharma PLC • Pharmaceutical preparations • New Jersey
Contract Type FiledDecember 29th, 2004 Company Industry JurisdictionSTOCK PURCHASE AGREEMENT (this “Agreement”) dated as of December 29, 2004 by and among Mike Ajnsztajn and Gaston Liebhaber (collectively referred to as the “Sellers” and individually as a “Seller”), and SkyePharma PLC, a company incorporated under the laws of England and Wales (the “Purchaser”).
EXHIBIT 3 [SKYEPHARMA LETTERHEAD] Vital Living, Inc. 5080 North 40th Street, Suite 105 Phoenix, Arizona 85018-2158 United States 20 August 2003 We refer to the Agreement and Plan of Merger (the "Merger Agreement"), by and among you ("Vital Living"),...Skyepharma PLC • August 29th, 2003 • Pharmaceutical preparations
Company FiledAugust 29th, 2003 Industry
SERVICE AGREEMENTService Agreement • June 30th, 2006 • Skyepharma PLC • Pharmaceutical preparations
Contract Type FiledJune 30th, 2006 Company Industry
SKYEPHARMA LETTERHEAD] Vital Living, Inc. 5080 North 40th Street, Suite 105 Phoenix, Arizona 85018-2158 United States 4 December 2003 We refer to the letter, dated as of 20 August 2003, as amended on 19 November 2003 (the "Commitment Letter"), from...Skyepharma PLC • December 8th, 2003 • Pharmaceutical preparations
Company FiledDecember 8th, 2003 Industry
DEVELOPMENT AND MARKETING STRATEGIC ALLIANCE AGREEMENT AMONG ENDO PHARMACEUTICALS INC. SKYEPHARMA, INC. AND SKYEPHARMA CANADA INC. DATED AS OF December 31, 2002Development, Marketing and Strategic Alliance Agreement • June 27th, 2003 • Skyepharma PLC • Pharmaceutical preparations • New York
Contract Type FiledJune 27th, 2003 Company Industry JurisdictionTHIS DEVELOPMENT, MARKETING AND STRATEGIC ALLIANCE AGREEMENT (this "Agreement"), dated as of the date first written above, is entered into by and among Endo Pharmaceuticals Inc., a corporation organized and existing under the laws of Delaware, having offices located at 100 Painters Drive, Chadds Ford, PA 19317 ("Endo"), SkyePharma, Inc., a corporation organized and existing under the laws of the State of California, having offices located at 10450 Science Center Drive, San Diego, CA 92121, for itself and on behalf of its subsidiaries, if any, and SkyePharma Canada Inc., a corporation organized and existing under the laws of Canada, having offices located at 1000 chemin du Golf, Verdun, Quebec, H3E 1H4 Canada, for itself and on behalf of its subsidiaries (collectively, SkyePharma, Inc., SkyePharma Canada Inc. and the subsidiaries of SkyePharma, Inc. and SkyePharma Canada Inc., "SkyePharma").
ASSIGNMENT AGREEMENTAssignment Agreement • December 29th, 2004 • Skyepharma PLC • Pharmaceutical preparations • New Jersey
Contract Type FiledDecember 29th, 2004 Company Industry JurisdictionThis ASSIGNMENT AGREEMENT, dated as of December 29, 2004 (this “Agreement”), is made and entered into by and among Mike Ajnsztajn and Gaston Liebhaber (collectively referred to as the “Assignors”) and SkyePharma PLC, a company incorporated under the laws of England and Wales (the “Purchaser”).
AMENDED AND RESTATED DEPOSIT AGREEMENTDeposit Agreement • June 4th, 2007 • Skyepharma PLC • Pharmaceutical preparations • New York
Contract Type FiledJune 4th, 2007 Company Industry JurisdictionAMENDED AND RESTATED DEPOSIT AGREEMENT dated as of July 8, 1998,June 4, 2007, among SKYEPHARMA PLC, a public limited company organized under the laws of England and Wales (herein called the Company), THE BANK OF NEW YORK, a New York banking corporation (herein called the Depositary), and all Owners and Beneficial Owners from time to time of American Depositary Receipts issued hereunder.